Abstract:Background: Recurrence prediction models for hepatocellular carcinoma liver transplantation in western countries already exist, but the differences in tumor biological characteristics among different populations. So we aim to create a Nomogram prediction model for predicting hepatocellular carcinoma liver transplantation patients in China to predict individual survival after surgery and guide the postoperative treatment. Materials and Methods: Between February 2016 and October 2019, 210 HCC patients who received liver transplantation in the Huashan Hospital Affiliated to Fudan University were collected for this study. Prognostic nomograms predicting post-transplant recurrence were developed from a multivariate cox regression. The prediction power of the nomograms was tested by C-statistic and calibration plots. Results: There were 46(21.9%) patients within the Milan criteria. Before transplantation,24(11.4%) patients received transcatheter arterial chemoembolization (TACE) and 9(4.3%) received tumor targeted therapy. Multivariate predictors of recurrence included Age, Max diameter, thrombus, MVI, ALT on the 7th day after surgery(7d-ALT),AFP on the 7th day after surgery(7d-AFP). Nomogram for recurrence free survival (RFS) have been created. Discrimination and calibration of the nomograms revealed good predictive abilities(C-index:0.796).Compared with Milan criteria(C-index:0.617), UCSF criteria(C-index:0.624), the RFS nomogram improved accuracy in predicting recurrence after transplantation for HCC.Finally, two subgroups were generated based on the total risk points. The 1-, 2-, and 3-year recurrence rate were 16.6%, 23.3%, and 26.9% for the low-risk group, and 52.4%, 80.1%, and 80.1% for the high-risk group, respectively.Conclusion: The nomogram made by using different examination indexes had good ability in predicting prognostic recurrence and guiding the follow-up of patients. It can achieve patient stratification and guide patients for treatment and follow-up. Patients with score above 312.1 points had high risk of early recurrence after LT. For these patients, more strict postoperative targeted treatment and follow-up are needed. In order to be convenient and practical, we have also made web prediction models for convenience and practicality. For example, a 45-year-old male (0 point), tumor maximum diameter of 7 cm (30.3 points), have tumor thrombus (78.8 point), MVI of 1 (36.9 points), ALT of 156u / L (25.1 points), AFP of 83 μ g / L (6.2 points) on the 7th day after operation. For this example, the total score is 177.3 points, so the predicted recurrence rate of 1 and 2 years is 18% and 31%. This calculated value can be used to develop treatment plans and communicate with patients.https://maensi.shinyapps.io/Huashan_surgery/

Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors

Nomogram for prediction of hepatocellular carcinoma recurrence after liver resection

Multi-Institutional Development and External Validation of a Nomogram for Prediction of Extrahepatic Recurrence After Curative-Intent Resection for Hepatocellular Carcinoma

Novel Prognostic Nomograms for Predicting Early and Late Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy

Pre- and Postoperative Models for Prediction of Recurrence in Non-B, Non-C Hepatocellular Carcinoma

Prognostic Nomograms and Risk Classifications of Outcomes in Very Early-Stage Hepatocellular Carcinoma Patients after Hepatectomy.

Development and Validation of a Nomogram for Predicting Postoperative Early Relapse and Survival in Hepatocellular Carcinoma

Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival

Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection

Development and External Validation of a Nomogram Including Body Composition Parameters for Predicting Early Recurrence of Hepatocellular Carcinoma After Hepatectomy

Development of a Predictive Nomogram for Early Recurrence of Hepatocellular Carcinoma in Patients Undergoing Liver Transplantation.

Nomogram Based on Systemic Immune Inflammation Index and Prognostic Nutrition Index Predicts Recurrence of Hepatocellular Carcinoma After Surgery

DEVELOPMENT OF NOMOGRAM PREDICTION MODEL FOR POSTOPERATIVE RECURRENCE OF HCC PATIENTS UNDERGOING LIVER TRANSPLANTATION IN CHINESE POPULATION WITH INTERNAL VALIDATION

Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics

YAP-based nomogram predicts poor prognosis in patients with hepatocellular carcinoma after curative surgery

Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection

Development and Validation of Pre- and Post-Operative Models to Predict Recurrence After Resection of Solitary Hepatocellular Carcinoma: A Multi-Institutional Study

Development and validation of nomograms to predict survival and recurrence after hepatectomy for intermediate/advanced (BCLC stage B/C) hepatocellular carcinoma

Development of a novel prognostic nomogram for the early recurrence of liver cancer after curative hepatectomy

New Nomogram Predicts the Recurrence of Hepatocellular Carcinoma in Patients with Negative Preoperative Serum AFP Subjected to Curative Resection.

Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus